# CAncer TReatment INformed by the Molecular Tumor Board At Dartmouth

> **NCT05405413** · PHASE2 · RECRUITING · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 192 (estimated)

## Conditions studied

- Cancer

## Interventions

- **OTHER:** Treatment recommendations made by Molecular Tumor Board.

## Key facts

- **NCT ID:** NCT05405413
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-19
- **Primary completion:** 2029-05
- **Final completion:** 2029-12
- **Target enrollment:** 192 (ESTIMATED)
- **Last updated:** 2025-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05405413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05405413, "CAncer TReatment INformed by the Molecular Tumor Board At Dartmouth". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT05405413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*